Walgreens Boots Alliance Inc (NASDAQ:WBA) — Market Cap & Net Worth
Market Cap & Net Worth: Walgreens Boots Alliance Inc (WBA)
Walgreens Boots Alliance Inc (NASDAQ:WBA) has a market capitalization of $10.37 Billion ($10.37 Billion) as of September 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2182 globally and #812 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Walgreens Boots Alliance Inc's stock price $11.98 by its total outstanding shares 865561024 (865.56 Million). Also see Walgreens Boots Alliance Inc assets under control for a full breakdown of the balance sheet.
Walgreens Boots Alliance Inc Market Cap History: 2015 to 2025
Walgreens Boots Alliance Inc's market capitalization history from 2015 to 2025. Data shows change from $51.00 Billion to $10.37 Billion (-15.20% CAGR). Also see WBA operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
Walgreens Boots Alliance Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$63.09 Trillion | 0.02% | #458 of 503 |
|
NASDAQ Composite
IXIC
|
$41.94 Trillion | 0.02% | #246 of 3165 |
|
S&P RETAIL SELECT INDUST
SPSIRE
|
$4.91 Trillion | 1.37% | #22 of 76 |
Weight: Walgreens Boots Alliance Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Walgreens Boots Alliance Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Walgreens Boots Alliance Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Walgreens Boots Alliance Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.05x
Walgreens Boots Alliance Inc's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $51.00 Billion | $103.44 Billion | $4.22 Billion | 0.49x | 12.09x |
| 2016 | $50.49 Billion | $117.35 Billion | $4.17 Billion | 0.43x | 12.10x |
| 2017 | $45.18 Billion | $118.21 Billion | $4.08 Billion | 0.38x | 11.08x |
| 2018 | $43.53 Billion | $131.54 Billion | $5.02 Billion | 0.33x | 8.66x |
| 2019 | $38.75 Billion | $120.07 Billion | $3.98 Billion | 0.32x | 9.73x |
| 2020 | $27.37 Billion | $121.98 Billion | $456.00 Million | 0.22x | 60.01x |
| 2021 | $37.17 Billion | $132.51 Billion | $2.54 Billion | 0.28x | 14.62x |
| 2022 | $27.88 Billion | $132.70 Billion | $4.34 Billion | 0.21x | 6.43x |
| 2023 | $20.89 Billion | $139.08 Billion | -$3.08 Billion | 0.15x | N/A |
| 2024 | $8.08 Billion | $147.66 Billion | -$8.64 Billion | 0.05x | N/A |
Competitor Companies of WBA by Market Capitalization
Companies near Walgreens Boots Alliance Inc in the global market cap rankings as of September 16, 2026. Review WBA goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Walgreens Boots Alliance Inc by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1941 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2552 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2977 globally with a market cap of $6.70 Billion USD ( R$34.17 Billion BRL).
- Yifeng Pharmacy (SHG:603939): Ranked #4115 globally with a market cap of $4.02 Billion USD ( CN¥27.47 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1941 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €3.79 |
| #2552 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2977 | Raia Drogasil S.A | SA:RADL3 | $6.70 Billion | R$19.54 |
| #4115 | Yifeng Pharmacy | SHG:603939 | $4.02 Billion | CN¥22.66 |
Walgreens Boots Alliance Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Walgreens Boots Alliance Inc's market cap moved from $51.00 Billion to $ 10.37 Billion, with a yearly change of -15.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.37 Billion | +28.40% |
| 2024 | $8.08 Billion | -61.34% |
| 2023 | $20.89 Billion | -25.06% |
| 2022 | $27.88 Billion | -25.00% |
| 2021 | $37.17 Billion | +35.81% |
| 2020 | $27.37 Billion | -29.37% |
| 2019 | $38.75 Billion | -10.99% |
| 2018 | $43.53 Billion | -3.65% |
| 2017 | $45.18 Billion | -10.51% |
| 2016 | $50.49 Billion | -1.01% |
| 2015 | $51.00 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 27th, 2026 the market cap of Walgreens Boots Alliance Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.37 Billion USD |
| MoneyControl | $10.37 Billion USD |
| MarketWatch | $10.37 Billion USD |
| marketcap.company | $10.37 Billion USD |
| Reuters | $10.37 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy… Read more